Correlation between Wnt signaling and T-cell infiltration in high-grade serous ovarian cancer

被引：1

作者：

Goldsberry, W. ^{[1
]}

Phillips, R. A., III ^{[2
]}

Montgomery, A. M. ^{[1
]}

Katre, A. A. ^{[1
]}

Doo, D. W. ^{[1
]}

Norian, L. A. ^{[1
]}

Randall, T. ^{[1
]}

Yemelyanova, A. ^{[1
]}

Cooper, S. J. ^{[2
]}

Arend, R. C. ^{[1
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL USA

[2] HudsonAlpha Inst Biotechnol, Huntsville, AL USA

来源：

GYNECOLOGIC ONCOLOGY | 2019年 / 154卷

关键词：

D O I：

10.1016/j.ygyno.2019.04.170

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1239

引用

页码：72 / 72

页数：1

共 50 条

[21] High-grade serous ovarian cancer: the clone wars [J].

Salomon-Perzynski, Aleksander ;

Salomon-Perzynska, Magdalena ;

Michalski, Bogdan ;

Skrzypulec-Plinta, Violetta .

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (03) :569-576

[22] Drugs Repurposing in High-Grade Serous Ovarian Cancer [J].

Torralba, Manuel ;

Farra, Rossella ;

Maddaloni, Marianna ;

Grassi, Mario ;

Dapas, Barbara ;

Grassi, Gabriele .

CURRENT MEDICINAL CHEMISTRY, 2020, 27 (42) :7222-7233

[23] Treatment with carboplatin and taxane chemotherapy increases T-cell receptor (TCR) clonality in high-grade serous ovarian cancer (HGSOC) [J].

LaVigne, K. ;

Cybulska, P. ;

Walther, T. ;

Emerson, R. O. ;

Vignali, M. ;

Park, K. J. ;

Levine, D. A. ;

Chi, D. S. ;

Zivanovic, O. ;

Charen, A. E. Snyder .

GYNECOLOGIC ONCOLOGY, 2017, 145 :20-21

[24] The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma [J].

Kim, Rachel Soyoun ;

Li, Xuan ;

Bernardini, Marcus ;

Hogen, Liat ;

May, Taymaa .

GYNECOLOGIC ONCOLOGY, 2021, 162 :S289-S289

[25] THE CORRELATION BETWEEN BRCA STATUS AND SURGICAL CYTOREDUCTION IN HIGH-GRADE SEROUS OVARIAN CARCINOMA [J].

Kim, R. S. ;

Malcolmson, J. ;

Li, X. ;

Bernardini, M. ;

Hogen, L. ;

May, T. .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 :A98-A98

[26] The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma [J].

Kim, Soyoun Rachel ;

Malcolmson, Janet ;

Li, Xuan ;

Bernardini, Marcus Q. ;

Hogen, Liat ;

May, Taymaa .

GYNECOLOGIC ONCOLOGY, 2021, 162 (03) :702-706

[27] Neurotensin signaling pathway as a potential therapeutic target in high-grade serous ovarian cancer [J].

Norris, E. J. ;

DeStephanis, D. ;

Zhang, Q. ;

Tait, D. L. ;

Ganapathi, R. ;

Ganapathi, M. .

GYNECOLOGIC ONCOLOGY, 2018, 149 :71-71

[28] Immune cell landscapes are associated with high-grade serous ovarian cancer survival [J].

Zhang, Guoan ;

Zhang, Yan ;

Zhang, Jingjing ;

Yang, Xiaohui ;

Sun, Wenjie ;

Liu, Ying ;

Liu, Yingfu .

SCIENTIFIC REPORTS, 2024, 14 (01)

[29] In vivo tumor growth of high-grade serous ovarian cancer cell lines [J].

Mitra, Anirban K. ;

Davis, David A. ;

Tomar, Sunil ;

Roy, Lynn ;

Gurler, Hilal ;

Xie, Jia ;

Lantvit, Daniel D. ;

Cardenas, Horacio ;

Fang, Fang ;

Liu, Yueying ;

Loughran, Elizabeth ;

Yang, Jing ;

Stack, M. Sharon ;

Emerson, Robert E. ;

Dahl, Karen D. Cowden ;

Barbolina, Maria V. ;

Nephew, Kenneth P. ;

Matei, Daniela ;

Burdette, Joanna E. .

GYNECOLOGIC ONCOLOGY, 2015, 138 (02) :372-377

[30] Amplified Cell Cycle Genes Identified in High-Grade Serous Ovarian Cancer [J].

Balakrishnan, Karthik ;

Chen, Yuanhong ;

Dong, Jixin .

CANCERS, 2024, 16 (16)

← 1 2 3 4 5 →